Beta Amyloid News and Research

RSS

New peptides improve memory in mice with Alzheimer’s

Alzheimer’s disease (AD) affects over 44 million people the world over. But now, neurologist Jack Jhamandas and his team have found two short peptides which, on daily injection into mice with symptoms of AD for just five weeks, led to a significant improvement.

18 Sep 2019

Chemist explores link between Alzheimer's and copper protein molecules in brain cells

A University of Houston chemist is exploring the link between copper protein molecules in brain cells and neurodegenerative diseases like Alzheimer's.

17 Sep 2019

Memory-protective drug for Alzheimer’s on the horizon

Scientists have come up with a new drug which could prevent patients with features of Alzheimer’s disease (AD) from suffering memory loss and brain damage.

10 Sep 2019

New insight and target for Alzheimer’s disease

The body is designed to fix anything that is out of balance. Homeostasis is maintained in the body, and even a minor change could trigger a compensatory mechanism, in the hopes of keeping everything stable.

4 Sep 2019

"Australian" genetic mutation provides clues to Alzheimer’s mechanism

In an astonishing new breakthrough in Alzheimer’s research, the molecular basis of early-onset Alzheimer’s disease (AD) and age-linked AD has been identified by looking at one type of genetic mutation.

26 Aug 2019

UCI study finds link between brain immune cells and Alzheimer's disease development

Scientists from the University of California, Irvine School of Biological Sciences have discovered how to forestall Alzheimer's disease in a laboratory setting, a finding that could one day help in devising targeted drugs that prevent it.

21 Aug 2019

Middle-life hypertension may shrink the brain in later life

A long-running study which ha been following up people into their seventies concludes that high blood pressure between the age of 36 and 53 years is associated with brain pathology such as white matter lesions and brain shrinkage in later life. To prevent this, blood pressure should be monitored beginning at or before 40 years, suggest the researchers.

21 Aug 2019

UCLA scientists discover new insights that may lead to progress in fighting Alzheimer's disease

More than three decades of research on Alzheimer's disease have not produced any major treatment advances for those with the disorder, according to a UCLA expert who has studied the biochemistry of the brain and Alzheimer's for nearly 30 years.

20 Aug 2019

Beta amyloid structure mapped in new Alzheimer’s research

In search of a possible cure for Alzheimer’s disease (AD), scientists have found out the molecular structure of a type of protein called beta amyloid that accumulates within brain cells, eventually killing them. This could help understand how to prevent these abnormal proteins from forming, leading to a cure or treatment for this killer disease.

13 Aug 2019

New research suggests another possible mechanism for Alzheimer’s

Neurofibrillary plaques and tau protein are among the most widely known pathological entities characterizing Alzheimer’s disease (AD), but new research at the University of California, Riverside, has come up with another plausible explanation for this debilitating disorder.

13 Aug 2019

Tissue model of Alzheimer's mimics beta-amyloid's effects on blood-brain barrier

Beta-amyloid plaques, the protein aggregates that form in the brains of Alzheimer's patients, disrupt many brain functions and can kill neurons. They can also damage the blood-brain barrier — the normally tight border that prevents harmful molecules in the bloodstream from entering the brain.

13 Aug 2019

Researchers identify alternate chemistry that could account for Alzheimer's pathologies

Alzheimer's disease, the most common cause of dementia among the elderly, is characterized by plaques and tangles in the brain, with most efforts at finding a cure focused on these abnormal structures.

13 Aug 2019

Engineers develop tissue model that mimics beta-amyloid's effects on blood-brain barrier

Beta-amyloid plaques, the protein aggregates that form in the brains of Alzheimer's patients, disrupt many brain functions and can kill neurons.

13 Aug 2019

Researchers identify direct toxic action of beta-amyloid in the brain

The brains of Alzheimer's patients who have already developed clinical symptoms contain large clumps of the protein beta-amyloid, known as plaques. Many therapeutic approaches focus on removing plaques, but such attempts have met with only limited success to date.

9 Aug 2019

Amyloid PET scan is not an effective method for measuring severity, progression of Alzheimer's

While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer's disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania and Thomas Jefferson University.

6 Aug 2019

Scientists study how mobile phones can be used to fight Alzheimer’s disease

Future treatments for age-related dementia could involve mobile phone frequency electromagnetic fields, researchers at Nazarbayev University and the National Laboratory Astana investigate.

6 Aug 2019

Alzheimers may be linked to genes that code formation of contacts between neurons

A team of neurobiologists from Peter the Great St. Petersburg Polytechnic University published an article on their study of the causes of Alzheimer's disease and suggested therapy methods.

2 Aug 2019

Altered protein and mutated clusters of genes in Alzheimer’s disease

Alzheimer's disease (AD) diagnosis and treatment has been a challenge and this is mainly due to the varying degrees of degeneration and cognitive damage seen in different patients. The researchers from the University of California San Diego School of Medicine for the first time used the transcriptome to assess the proteins made from the genes in patients with AD, that could help in diagnosis.

23 Jul 2019

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

The Alzheimer's Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, a $3 million grant to be applied to the company's mesenchymal stem cell Alzheimer's research.

23 Jul 2019

Study highlights the need for larger Alzheimer's drug trials that intervene much earlier

There are currently no drugs that stop or inhibit Alzheimer's disease. Despite drug trials showing plaque reduction in the brain, the patients' cognitive function did not improve.

11 Jul 2019

Beta Amyloid News and Research

New peptides improve memory in mice with Alzheimer’s

Chemist explores link between Alzheimer's and copper protein molecules in brain cells

Memory-protective drug for Alzheimer’s on the horizon

New insight and target for Alzheimer’s disease

"Australian" genetic mutation provides clues to Alzheimer’s mechanism

UCI study finds link between brain immune cells and Alzheimer's disease development

Middle-life hypertension may shrink the brain in later life

UCLA scientists discover new insights that may lead to progress in fighting Alzheimer's disease

Beta amyloid structure mapped in new Alzheimer’s research

New research suggests another possible mechanism for Alzheimer’s

Tissue model of Alzheimer's mimics beta-amyloid's effects on blood-brain barrier

Researchers identify alternate chemistry that could account for Alzheimer's pathologies

Engineers develop tissue model that mimics beta-amyloid's effects on blood-brain barrier

Researchers identify direct toxic action of beta-amyloid in the brain

Amyloid PET scan is not an effective method for measuring severity, progression of Alzheimer's

Scientists study how mobile phones can be used to fight Alzheimer’s disease

Alzheimers may be linked to genes that code formation of contacts between neurons

Altered protein and mutated clusters of genes in Alzheimer’s disease

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

Study highlights the need for larger Alzheimer's drug trials that intervene much earlier

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News